Skip to main content
. 2012 May 31;109(34):E2276–E2283. doi: 10.1073/pnas.1115240109

Table 1.

Histological response of GIST lesions in KitV558Δ/+ and KitV558Δ;T669I/+ mice to 7-d treatment with imatinib, dasatinib, sunitinib, or sorafenib

Strain Vehicle Imatinib Dasatinib Sunitinib Sorafenib
KitV558Δ/+ None Minimal Minimal Minimal Moderate
None None Minimal None Mild
None None Minimal Minimal Mild
None
None
KitV558Δ;T669I/+ None None None None Minimal
None None None None Minimal
None None None None Minimal
Minimal Minimal Minimal-mild
None Minimal Mild
None Minimal